SPAC Daily: Return of Merger Monday

by | Jul 25, 2022

For the first time in recent memory, we had a fairly active SPAC merger Monday with 3 (yes!) 3 new DAs:

  • Frazier Life Sciences Acquisition Corp. (FLAC) and NewAmsterdam Pharma, $326M
  • DUET Acquisition Corp. (DUET) and AnyTech 365, $287M
  • DHC Acquisition Corp. (DHCA) and GloriFi, $1.7B

However, that brings us to GloriFi. Not taking a view on the deal yet (tough to with little information released), though a $1.7B valuation is a bit of head scratcher for a company that feels as if is in a very WIP mode. To boot, this was at the bottom of their Press Release: “Given the Summer Holiday Season, GloriFi intends to Post its Full Investor Presentation After Labor Day”

From GloriFi’s website, looks like most products have yet to launch

That’s definitely a first and doesn’t exactly scream, hey we’re working hard for you. If you can’t even bother to work on a presentation until after Labor Day, what is the point of rushing to announce in July? Watch out high redemptions!

Elsewhere in SPACs

  • Better World Acquisition Corp. (BWAC) set a date for another extension. vote 8/15, out till feb. 44% redeemed in last vote.
  • Abri SPAC (ASPA) and blockchain co Apifiny terminated their previously announced deal. ASPA will look for another target.

Upcoming SPAC Calendar

Full calendar and SPAC database access here

Today’s Price Action

Biggest Gainers

4.16% ~ $ 9.27 | WALD – Waldencast Acquisition Corp. (Announced)
2.49% ~ $ 10.29 | TRON – Corner Growth Acquisition Corp. 2 (Pre-Deal)
.81% ~ $ 9.95 | BCAC – Brookline Capital Acquisition Corp. (Pre-Deal)
.80% ~ $ 10.10 | VMCA – Valuence Merger Corp. I (Pre-Deal)
.71% ~ $ 9.88 | CLAA – Colonnade Acquisition Corp. II (Pre-Deal)
.62% ~ $ 9.73 | HWEL – Healthwell Acquisition Corp. I (Pre-Deal)
.61% ~ $ 9.91 | VBOC – Viscogliosi Brothers Acquisition Corp (Pre-Deal)
.52% ~ $ 9.75 | ALCC – AltC Acquisition Corp. (Pre-Deal)
.52% ~ $ 9.75 | IPAX – Inflection Point Acquisition Corp. (Pre-Deal)
.51% ~ $ 9.83 | GAQ – Generation Asia I Acquisition Ltd (Pre-Deal)
.51% ~ $ 9.90 | IVCP – Swiftmerge Acquisition Corp. (Pre-Deal)
.51% ~ $ 9.94 | FCAX – Fortress Capital Acquisition Corp (Pre-Deal)
.50% ~ $ 10.14 | TOAC – Talon 1 Acquisition Corp (Pre-Deal)
.45% ~ $ 9.99 | DCRD – Decarbonization Plus Acquisition Corp IV (Pre-Deal)
.41% ~ $ 9.70 | JAQC – Jupiter Acquisition Corporation (Pre-Deal)
.41% ~ $ 9.74 | DALS – DA32 Life Science Tech Acquisition Corp. (Pre-Deal)
.41% ~ $ 9.76 | FICV – Frontier Investment Corp (Pre-Deal)
.41% ~ $ 9.76 | DUNE – Dune Acquisition Corporation (Announced)
.41% ~ $ 9.76 | CLBR – Colombier Acquisition Corp. (Pre-Deal)
.41% ~ $ 9.89 | ITQ – Itiquira Acquisition Corp. (Pre-Deal)

Biggest Losers

-5.61% ~ $ 9.42 | CHWA – CHW Acquisition Corp (Announced)
-1.87% ~ $ 31.00 | DWAC – Digital World Acquisition Corp. (Announced)
-1.25% ~ $ 9.48 | NLIT – Northern Lights Acquisition Corp. (Announced)
-1.00% ~ $ 9.91 | GLTA – Galata Acquisition Corp (Pre-Deal)
-.60% ~ $ 9.87 | LCW – Learn CW Investment Corp (Pre-Deal)
-.50% ~ $ 10.00 | PWUP – PowerUp Acquisition Corp. (Pre-Deal)
-.49% ~ $ 10.17 | ACEV – ACE Convergence Acquisition Corp (Announced)
-.44% ~ $ 10.07 | CLAY – Chavant Capital Acquisition Corp. (Pre-Deal)
-.40% ~ $ 9.92 | STET – ST Energy Transition I Ltd. (Pre-Deal)
-.40% ~ $ 10.02 | CFVI – CF Acquisition Corp. VI (Announced)
-.31% ~ $ 9.67 | CDAQ – Compass Digital Acquisition Corp. (Pre-Deal)
-.31% ~ $ 9.70 | BWC – Blue Whale Acquisition Corp I (Pre-Deal)
-.30% ~ $ 9.81 | RACB – Research Alliance Corp. II (Pre-Deal)
-.30% ~ $ 9.82 | LVRA – Levere Holdings Corp (Pre-Deal)
-.30% ~ $ 9.84 | TRIS – Tristar Acquisition I Corp. (Pre-Deal)
-.30% ~ $ 9.93 | GDST – Goldenstone Acquisition Ltd. (Announced)
-.30% ~ $ 9.94 | FATP – FAT PROJECTS ACQUISITION CORP (Pre-Deal)
-.30% ~ $ 9.96 | ALSA – Alpha Star Acquisition Corp (Pre-Deal)
-.30% ~ $ 10.01 | LVAC – LAVA Medtech Acquisition Corp. (Pre-Deal)
-.30% ~ $ 10.04 | LFAC – LF Capital Acquisition Corp. II (Pre-Deal)

<a href="" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – July 2022

Liquidations, cancelled deals, and a dead IPO market highlight Boardroom Alpha’s July 2022 SPAC market review. Read for a full recap.

SPAC Market Review – June 2022

Boardroom Alpha’s June 2022 SPAC market review looks at the latest trends in SPACs, where the market is heading a recap of activity.

SPAC Market Review – May 2022

Inflation, rising interest rates, and reduced corporate earnings across the board have led to persistent market gyrations which prove its too early for bottom fishing. The stampede out of deSPACs now makes it ‘deal-or-die’ time for those without targets.

SPAC Research & Analysis

Boardroom Alpha Digest: Mon, Jan 9

Rite Aide Corporation (RAD) parts ways with Heyward Donigan and Paya Holdings (PAYA) acquisition highlight Monday’s daily digest.

Boardroom Alpha Digest: Thurs, Jan 5

Boardroom Alpha’s Daily Digest highlights include Elizabeth Spaulding resigning as CEO of Stitch Fix (SFIX) and JNJ’s Kenvue filing for an IPO

SPAC Market Review – December 2022

December’s SPAC market review takes a look by the numbers of the month’s SPAC activity and how the market currently stands going into 2023.

SPACs Today: Wednesday, Dec 14

Rice Acquisition Corp. II (RONI) with an encouraging energy transaction, and the rest of the day’s SPAC news.

SPACs Today: Monday, Dec 12

Venus Acquisition Corporation (VENA) finally closed and changes ticker to MLGO, and the rest of the day’s SPAC news.

SPAC Market Review – November 2022

November’s SPAC market review paints a picture of a SPAC market rushing towards the exit with high, and accelerating liquidations, more deal terminations, and almost no new SPAC IPOs.

Know Who Drives Return Podcast

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. WindAcre increases its stake and opposes NSLN takeover bid. Activist Jana Partners brings lessons learned at ConAgra (CAG) to Treehouse Foods (THS). And other notable special situations.

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. Management shakeup at Faraday Future (FIFE) is an all-too familiar story in the world of EV SPACs. Blackrock to be 75% net-zero aligned by 2030, and Jana closing in (again) at Treehouse Foods (THS).

FOXO Technologies CEO Jon Sabes Is About to Disrupt the Insurance Industry

Boardroom Alpha talks to Jon Sabes, CEO of FOXO Technologies, which announced a SPAC merger with sponsor Delwinds Insurance Acquisition Corp. (DWIN). Sabes explains how epigenetic biomarkers can change the game for life insurance companies and tell us more about health and wellness than ever before.


The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.